Quantum Biopharma Ltd. Files October 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Oct 3, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Oct 3, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, company-name-change
TL;DR
Quantum Biopharma (formerly FSD Pharma) filed its October 6-K, confirming its foreign private issuer status.
AI Summary
Quantum Biopharma Ltd. filed a Form 6-K on October 3, 2025, reporting for the month of October 2025. The company, formerly known as FSD Pharma Inc. until March 27, 2019, is based in Toronto, Ontario, Canada. This filing is a report of a foreign private issuer.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Quantum Biopharma's status as a foreign private issuer. It confirms their reporting obligations and location.
Risk Assessment
Risk Level: low — This filing is a routine disclosure for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer
- FSD Pharma Inc. (company) — Former company name
- October 3, 2025 (date) — Filing date
- Toronto, Ontario (location) — Company headquarters
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of a foreign private issuer required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
When was Quantum Biopharma Ltd. formerly known as?
Quantum Biopharma Ltd. was formerly known as FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd. located?
Quantum Biopharma Ltd.'s principal executive office is located at 1 Adelaide Street East, Suite 801, Toronto, Ontario M5C 2V9.
Does Quantum Biopharma Ltd. file an annual report under Form 20-F or 40-F?
Quantum Biopharma Ltd. indicates it files annual reports under cover of Form 20-F.
What is the SIC code for Quantum Biopharma Ltd.?
The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, Pharmaceutical Preparations.
Filing Stats: 152 words · 1 min read · ~1 pages · Grade level 11.9 · Accepted 2025-10-03 07:00:29
Filing Documents
- f6k_100225.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 9KB
- 0001171843-25-006258.txt ( ) — 16KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Quantum BioPharma Ltd. (Registrant) Date: October 3, 2025 /s/ Donal Carroll Donal Carroll Chief Financial Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release dated October 3, 2025